Questions

891. Deputy Ken O'Flynn asked the Minister for Health whether any procurement process, competitive tender, or formal selection procedure was undertaken in respect of external partners involved in the development of the proposed training package; and if not, the basis for their appointment. [32206/26]

892. Deputy Ken O'Flynn asked the Minister for Health the expected timeline for the development, pilot, evaluation and national rollout of the proposed self-harm and suicide prevention training package for trainee general practitioners. [32207/26]

893. Deputy Ken O'Flynn asked the Minister for Health to detail the quality assurance and evaluation mechanisms that will apply to the proposed training package; whether outcome metrics, clinical impact assessments, or independent reviews are planned. [32208/26]

894. Deputy Ken O'Flynn asked the Minister for Health to clarify the relationship between the proposed self-harm and suicide prevention training package for trainee general practitioners and the forthcoming national strategy Connecting for Life 2026–2035; and to specify the oversight arrangements within her Department for programmes delivered under that strategy. [32209/26]

895. Deputy Colm Burke asked the Minister for Health to clarify the 5 January 2026 memo from the HSE Codeine Working Group instructing that low dose codeine-containing products should not be stocked routinely in clinical areas in any HSE or HSE-funded service, and that they be removed from clinical stock by 5 June 2026; if she will confirm whether this reflects official Department of Health or HSE policy; and if she …

896. Deputy Colm Burke asked the Minister for Health to clarify claims in the 5 January 2026 HSE memo that low-dose codeine combination products are no more effective than paracetamol or ibuprofen alone; to identify the evidence base for this; to confirm current policy on managing chronic pain; and if she will make a statement on the matter. [32234/26]

897. Deputy Colm Burke asked the Minister for Health if she will provide details of the HPRA’s engagement with patient groups and stakeholders during its ongoing review of over-the-counter codeine medicines which commenced in November 2022, including which organisations were consulted and the nature of that engagement; and if she will make a statement on the matter. [32235/26]

898. Deputy Colm Burke asked the Minister for Health if she is satisfied that the HPRA review process on over-the-counter codeine medicines meets the required standards of transparency, proportionality and scientific rigour; and if she will make a statement on the matter. [32236/26]

899. Deputy Colm Burke asked the Minister for Health to clarify the basis for the 5 January 2026 memo of the HSE codeine working group on low-dose codeine stating that low dose paracetamol ibuprofen are no more effective than paracetamol or ibuprofen alone for the management of pain; to instruct that low-dose codeine products should not be stocked routinely in clinical areas in any HSE or HSE-funded service, to remov…

900. Deputy Cathal Crowe asked the Minister for Health if the Government supports the inclusion of a distinct health “window” within the next Multiannual Financial Framework (MFF) 2028-2034, with earmarked funding to secure the continuation of key initiatives such as Europe’s Beating Cancer Plan and the EU Cancer Mission; and if she will make a statement on the matter. [32238/26]

901. Deputy Cathal Crowe asked the Minister for Health if the Government will designate health as a priority during Ireland’s forthcoming EU Presidency; if she will commit to hosting a Presidency-level event on Europe’s Beating Cancer Plan as a flagship initiative for prevention policies across Member States; and if she will make a statement on the matter. [32239/26]

902. Deputy Ken O'Flynn asked the Minister for Health whether a standardised national dataset exists capturing all presentations of suicidal ideation and self-harm across both emergency departments and primary care settings; if not, the steps being taken to establish such a dataset; and the timeline for its implementation. [32242/26]

903. Deputy Ken O'Flynn asked the Minister for Health the extent to which data on suicidal ideation and self-harm presentations in primary care is currently collected, centrally aggregated, and reported; and whether this data is subject to any national reporting framework. [32243/26]

904. Deputy Ken O'Flynn asked the Minister for Health whether the data collected through the Suicide Crisis Assessment Nurse (SCAN) service is subject to independent validation or audit; and if she will outline the governance arrangements in place to ensure data accuracy and completeness. [32244/26]

905. Deputy Ken O'Flynn asked the Minister for Health what specific key performance indicators (KPIs) are used within the National Clinical Programme for Self-harm and Suicide-related Ideation; whether these KPIs are published; and if she will provide the most recent performance data against those KPIs. [32245/26]

906. Deputy Ken O'Flynn asked the Minister for Health the number of clinical audits or programme reviews have been conducted in respect of the National Clinical Programme for Self-harm and Suicide-related Ideation in the years 2023, 2024 and to date in 2026; and if she will provide a summary of findings and recommendations arising. [32246/26]

907. Deputy Ken O'Flynn asked the Minister for Health whether outcome data is systematically collected following intervention for individuals presenting with suicidal ideation or self-harm, including re-presentation rates, follow-up engagement, and recovery indicators; and if not, whether there are plans to introduce such measures. [32247/26]

908. Deputy Ken O'Flynn asked the Minister for Health whether all adverse incidents related to suicidal ideation and self-harm presentations are consistently recorded within the National Incident Management System (NIMS); and whether a specific classification exists to allow for national reporting and trend analysis. [32248/26]

909. Deputy Ken O'Flynn asked the Minister for Health the way in which data from the National Incident Management System is used at Departmental level to inform suicide prevention policy, service planning, and risk mitigation strategies. [32249/26]

910. Deputy Ken O'Flynn asked the Minister for Health the formal oversight structures that exist within her Department to monitor the performance, data quality, and governance of the National Clinical Programme for Self-harm and Suicide-related Ideation. [32250/26]

911. Deputy Ken O'Flynn asked the Minister for Health whether a structured, recurring national audit schedule exists for suicide prevention services across both acute and community settings; and if not, whether she will establish such a framework. [32251/26]

912. Deputy Ken O'Flynn asked the Minister for Health whether participation in the SCAN data collection system is mandatory across all primary care settings; and if not, the proportion of services currently submitting data and the measures in place to ensure full national coverage. [32252/26]

913. Deputy Ken O'Flynn asked the Minister for Health which body holds ultimate responsibility for governance, validation, and publication of national data relating to suicidal ideation and self-harm presentations; and whether this responsibility is formally defined in policy. [32253/26]

914. Deputy Johnny Guirke asked the Minister for Health in relation to the free contraception scheme, the reason commonly used contraceptive medication such as elvina are still excluded; the steps being taken to ensure this scheme becomes genuinely inclusive of all available prescribed contraceptive pills; the processes in place to review and reconsider whether each type of pill is included for funding; and if she wi…

915. Deputy Peadar Tóibín asked the Minister for Health the number of protected disclosures that have gone missing or have been compromised that have been submitted to her Department or State bodies that are responsible to her Department. [32290/26]